Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. - Wikidata - wikimedia - TriplyDB

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

http://www.wikidata.org/entity/Q34007524

about

Clinical applications of mesenchymal stem cells Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation Therapy Effects of Bone Marrow Stromal Cells on Ischemic Stroke The Immunomodulatory Effects of Mesenchymal Stem Cells in Prevention or Treatment of Excessive Scars Mesenchymal stem cells and immunomodulation: current status and future prospects The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization The potential of mesenchymal stem cells in the management of radiation enteropathy Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells Mesenchymal stem cells, autoimmunity and rheumatoid arthritis Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells Some basic aspects of HLA-G biology The dual role of HLA-G in cancer Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications Immunomodulatory properties of HLA-G in infectious diseases Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications Interactions between MSCs and immune cells: implications for bone healing.Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?Endocytosis of indium-tin-oxide nanoparticles by macrophages provokes pyroptosis requiring NLRP3-ASC-Caspase1 axis that can be prevented by mesenchymal stem cells Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response Activation of regulatory T cells during inflammatory response is not an exclusive property of stem cells Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges Mesenchymal stem cells as potential therapeutic approaches in celiac disease Clinical applications of mesenchymal stem cells in chronic diseases.Synthetic HLA-G proteins for therapeutic use in transplantation.Mesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease.Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.Strategies to rescue mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) from NK cell mediated cytotoxicity.Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.

P2860

Q21198864-3E63C028-DB1E-4D41-A147-75459A1A50D6 Q24293562-AF6955DF-57E3-4160-BFCD-8661B88A444C Q24297200-9365584E-710F-4328-A1C8-3903B771492B Q24632756-806580FE-EB34-4A67-859F-9E456C1EE5DD Q24644691-7F97318E-5EA3-4A77-89B8-222DF5BCD6DE Q26741252-984BE9A3-EC96-46F1-8DA8-E0E205D69B1E Q26748595-5A15F7BF-64BB-4F63-BC4A-49A150B5B1DD Q26749052-3AB97665-B61B-4CE8-B448-537D82FC8203 Q26770100-47B425DD-A30F-4B51-BF6A-934ACDD66C69 Q26770191-A8F5A0A0-20F4-4B7F-8241-4ADC39F3F817 Q26773017-C5C4020E-3F7F-477C-AF53-196FF7B644EF Q26799905-2D87524F-9816-471A-BDFA-446A80C4C5A2 Q26800098-9DC7C721-E5FE-4555-8789-037BE8789120 Q26801540-BAE80087-0842-4048-B361-825E743AC558 Q26801575-E8C29964-3A06-42B1-87F7-A0C6FEC6BA6B Q26822005-CAB15C74-4129-41EF-99F3-DEC2DC598D82 Q26828950-CC1436F9-AAF9-46EB-B67D-755991AB0A0A Q26852467-6D960315-B125-4B6A-BF1C-D61AB1EB50F1 Q26852671-3834C12E-95E3-4BE0-B542-51A3E73B71B4 Q26860886-B0962A27-B1A3-4D46-BFC3-9BA244F848B2 Q26864580-F3BD643E-A4FF-4168-9AD8-3B961D368D4E Q27004008-DE7BFE46-0FF0-4DCA-9BE0-5AA097B2E5C0 Q27013645-D1733ED9-537D-425B-A920-B63B0A768904 Q27026892-72FA3BCE-D189-4FCA-B1A2-106366D56B09 Q27308223-AD757C7A-D9C0-4E57-8159-DED4538EF5A0 Q28074203-84C392E5-87BA-462B-A79C-ACA1910116CF Q28079823-D8B53E4E-1181-4636-AE76-085364AD2F3D Q28083741-1F327D28-2A6D-464B-A67E-5D48F491D384 Q28084829-68D8374B-1EBA-4A4E-B0DF-6E6DBEDA38A9 Q28394649-7038F45E-51A3-4C99-9334-CA0F58DC83FB Q28534075-560E4349-614A-4942-9B55-04D8CEF49E93 Q28730432-C89683DC-1148-41C7-A1A6-836BDDF8D3E3 Q30009860-D084225D-4852-456A-A05C-CD1FA66F3932 Q30235617-85CFBB62-553C-4957-9AB9-FAB616684205 Q30437823-23C8B470-25C9-4710-BB56-6BCE26B27B40 Q30543621-B62D4517-EC2D-4331-9E5E-EE98D122B263 Q30585387-27DE9438-1250-4BFC-A36F-ADD795113C11 Q30660529-58659AC6-B1D0-4AE5-A114-D8DAB6550655 Q30980207-6DF0020B-2E99-41F2-95E3-4896E28CD19B Q31101562-E7E87CDE-2E2A-4040-B19B-7D71BDDEE83E

P2860

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

http://www.wikidata.org/entity/Q34007524

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@ast

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@en

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@nl

type

label

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@ast

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@en

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@nl

prefLabel

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@ast

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@en

Human leukocyte antigen-G5 sec ...... highFOXP3+ regulatory T cells.

@nl

P1433

Q34007524-AB209538-30D4-4284-AD36-443CAB3EF26F

P1476

Q34007524-CF2FD621-32C5-469B-8654-A8B4D476646D

P2093

Q34007524-20F79245-CE2B-4B9C-867A-3DF3172CD412

Q34007524-27BC9D01-4EB0-4705-BFD9-CAE8AB0F330D

Q34007524-4254F517-0DDA-4E83-B1F5-891D95D8501A

Q34007524-4CAAE7EC-04F0-4F17-A336-FCBF07F9309B

Q34007524-7EB48B65-F01D-4795-9C1D-291D19304A42

Q34007524-A69107E0-36C2-4C43-A47B-B37A1733407B

Q34007524-B7AA5A25-48F1-40A3-B922-251C94817486

Q34007524-B7B27F66-4137-4652-9F02-8F43DA4E01D2

Q34007524-D6370206-9CE1-4EC6-B44F-8CC6D251B6EA

Q34007524-E860F92D-BFBF-451B-BB0F-AE9F4C9A8078

P304

Q34007524-01A713E1-4E60-4F3A-89F4-93F79DDF26A7

P31

Q34007524-6EB13B9A-2A86-430A-B37A-EE2C770C49EE

P356

Q34007524-9EAD699D-674D-44A7-9F66-06E479ED7ACE

P433

Q34007524-FF81B195-854A-4FCE-A1A5-A980AE9B7BD6

P478

Q34007524-42B388C3-70E9-4811-97CF-BF36DCF6272C

P50

Q34007524-C78C2A27-9795-4E08-B9E0-9F3D2D1FB5FC

Q34007524-F6A8EA70-9F7A-4548-93CB-BB2D1465EC26

P577

Q34007524-177C5379-FC3A-4E97-8F3D-2CAF55F7A0B4

P5875

Q34007524-B8B4E008-9BEE-4392-84CC-894D4718E951

P698

Q34007524-94377138-31EA-4847-BEAF-4D4ED434AA6A

P356

STEMCELLS.2007-0554

P1433

P1476

Human leukocyte antigen-G5 sec ...... 5highFOXP3+ regulatory T cells

@en

P2093

Abderrahim Naji

http://www.w3.org/2001/XMLSchema#string

Benoit Favier

http://www.w3.org/2001/XMLSchema#string

Christophe Borg

http://www.w3.org/2001/XMLSchema#string

Edgardo D Carosella

http://www.w3.org/2001/XMLSchema#string

Emilie Gaiffe

http://www.w3.org/2001/XMLSchema#string

Frederic Deschaseaux

http://www.w3.org/2001/XMLSchema#string

Laurent Obert

http://www.w3.org/2001/XMLSchema#string

Nathalie Rouas-Freiss

http://www.w3.org/2001/XMLSchema#string

Pierre Tiberghien

http://www.w3.org/2001/XMLSchema#string

Zohair Selmani

http://www.w3.org/2001/XMLSchema#string

P304

212-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/STEMCELLS.2007-0554

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5913628

http://www.w3.org/2001/XMLSchema#string

P698

17932417

http://www.w3.org/2001/XMLSchema#string